Global Menstrual Cramps Treatment Market is expected to grow with the CAGR of 7.8% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.
Global menstrual cramps treatment market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.
The major players dealing in global menstrual cramps treatment market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement into the market. This helped companies to maximize the sales with enhanced product portfolio.
GlaxoSmithKline plc. is the dominating player in global menstrual cramps treatment market. The other key players existing in the market includes Bayer AG, Pfizer Inc., Teva Pharmaceuticals USA, Inc. (A subsidiary of Teva Pharmaceutical Industries Ltd.), Color Seven Co., Ltd., Beurer GmbH, Mylan N. V. (A part of Viatris Inc.), Boehringer Ingelheim International GmbH, PMS4PMS, LLC, Sanofi, Nobelpharma Co., Ltd., ObsEva, Myovant Sciences Ltd., AbbVie Inc., BioElectronics Corporation, LIVIA, Alvogen, Cumberland Pharmaceuticals Inc., Lupin Pharmaceuticals, Inc. (a subsidiary of LUPIN), Janssen Pharmaceuticals, Inc. (A subsidiary of Johnson & Johnson Services, Inc.), Sun Pharmaceutical Industries Ltd.
GlaxoSmithKline plc was founded in 1715 and is headquartered in Middlesex U.K. They utilize the most recent innovation to bring genuine, human help to assist individuals with accomplishing their wellbeing objectives through supportable way of life change. Company mainly focus on the vaccines, consumer healthcare products, dermatology and others and dealing in the business segments such as pharmaceuticals, vaccines, consumer healthcare and among which pharmaceuticals is the market focussed segment. The product categories provided by the company are Our prescription medicines and vaccines, our consumer healthcare products, VIV healthcare, stiefel- dermatology among which our consumer healthcare products is the market focused category.
The company has presence across North America, Europe, Asia-Pacific, Middle East & Africa, South & Central America and earning revenue from its various subsidiaries such as 1506369 Alberta ULC (Canada), Action Potential Venture Capital Limited (England), Adechsa GmbH (Switzerland), Alenfarma – Especialidades Farmaceuticas, Limitada (Portugal), Allen & Hanburys Pharmaceutical Nigeria Limited (Nigeria) among others.
Janssen Pharmaceuticals, Inc. (A Subsidiary of Johnson & Johnson Services, Inc.)
Janssen Pharmaceuticals, Inc. (A Subsidiary of Johnson & Johnson Services, Inc) is headquartered in Titusville, New Jersey. The company is focusing on cardiovascular & metabolism, immunology, infectious diseases & vaccines, neuroscience, oncology and pulmonary hypertension therapeutic area. Moreover, the company is exclusively concentrating on bringing life-saving and life-changing solutions, the company provide products such as Micronor, Necon, Ortho, Ortho M-21, Ortho Novum, Ortho Tri-Cyclen, Ortho-Cyclen, Ortho-Novum, Nizoral Cream, Nizral, Nobligan, Nucynta, Motilium among many others among which Micronor, Necon, Ortho, Ortho M-21, Ortho Novum, Ortho Tri-Cyclen, Ortho-Cyclen, Ortho-Novum are the market focused segments.
The company has wide presence across Africa, Middle East, Americas, Asia-Pacific, and Europe.
Teva Pharmaceuticals USA, Inc. (A Subsidiary of Teva Pharmaceutical Industries Ltd.):
Teva Pharmaceuticals USA, Inc. (A Subsidiary of Teva Pharmaceutical Industries Ltd.). was founded in 1901 and is headquartered in New Jersey, U.S. The company is highly focusing on generic and specialty medicines portfolio as well as concentrating on strengthening consumer awareness of the benefits of generic medicines through partnerships and digital marketing programs. The company provides products such as generic medicines, biopharmaceuticals, specialty medicines among which generic medicines is the market focussed category.
The company has wide presence across North America.
Global Menstrual Cramps Treatment Market – Industry Trends and Forecast to 2028
Asia-Pacific Menstrual Cramps Treatment Market – Industry Trends and Forecast to 2028
Europe Menstrual Cramps Treatment Market – Industry Trends and Forecast to 2028
Middle East and Africa Menstrual Cramps Treatment Market – Industry Trends and Forecast to 2028
North America Menstrual Cramps Treatment Market – Industry Trends and Forecast to 2028